1. R Adisa,M ; Alutundun,T R; Fakeye (2009). Factors contributing to nonadherence to nonadhenrence to oral hypoglycaemic medications among ambulatory type 2 diabetes patients in South Western Nigeria. Pharmacy Practice (Internet), 7(3), 163-169.
2. A Al-Mehza,F M; Al-Muhailiye,M A; Khalfan,A Al-Yahaya (2009). Drug compliance among hypertensive patients; an area based study. European Journal of General Medicine, 6(1), 6-10.
3. A Aviles,E G; Alvara-Solis,R; Martinez-Vacquez,R Ponce-Rosis (2007). Disease Knowledge among Type 2 diabetes patients attending primary care. Gac. Med. Mex, 143(6), 453-462.
4. Brian Cross (2006). Hypertension in Text book of therapeutics-Drug and disease management Richard A. Helms et al Ed, 8, 451-485.
5. O Busari,T Olanrewaju,O O; Desalu,A O; Jimoh,S K; Agboola,O Busari,O E; Olalekan (2010). Impact of patients' Knowledge, Attitude and Practices on Hypertension on Compliance with Antihypertensive Drugs in a Resource-poor Setting. TAF Preventive Medicine Bulletin, 9(2), 87-92.
6. A Chobanian,G V; Bakris,H Black,W R;C Ushman,L C; Green,J Izzo,D Jones,B W;Materson,S; Oparil,J Wright,E T; Rocella (2003). Seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of high blood pressure. Hypertension, 42, 1206-1252.
7. H Davis M Mellus,I Stratton (1999). Risks factors for stroke in type 2 DM. United Kingdom Prospective Diabetic study (UKPDS) 29. Arch. Intern. Med, 159, 1097-1103.
8. (1993). The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-term Complications in Insulin-dependent Diabetes Mellitus. Retina, 14(3), 286-287.
9. Todd Gress,F Nieto,Eyal Shahar,Marion Wofford,Frederick Brancati (2000). Hypertension and Antihypertensive Therapy as Risk Factors for Type 2 Diabetes Mellitus. New England Journal of Medicine, 342(13), 905-912.
10. S Haffner,T Lehtos,T Ronnmaa (1998). mortality from coronary heart disease in subject with type 2 diabetes and non diabetic subject with and without prior myocardict intarction. N. Eng. J. Med, 339, 229-234.
11. L,Brain Cross (2006). The JNC 7 report (HYPERTENSION) in Textbook of Therapeutics, Drug and disease management Richard A. Helms et al Ed, 8, 451-455.
12. N Nisar,I Khan,M H Qadri,S Sher (2008). Knowledge and Risk assessment of diabetes mellitus at primary care level: A Preventive approach required combating the disease in a developing country. Pakistan Journal of Medical Science, 24, 667-672.
13. M Omole,A Suberu,O Itiola (2008). The Degree of Non-Compliance with Prescribed Drug Regimen in Hypertensives Attending An Out Patient Clinic In a Tertiary Hospital in South West Nigeria. West African Journal of Pharmacy, 21(1), 17-20.
14. M Omole,A Suberu (2010). Effects of Educational level on Hypertensive patients' compliance with medication regimen at a tertiary hospital in South West Nigeria. Nigerian Journal of Pharmaceutical Research, 8(1), 36-42.
15. Lars Osterberg,Terrence Blaschke (2005). Adherence to Medication. New England Journal of Medicine, 353(5), 487-497.
16. Robert Weibert (1992). The JNC 4 report (HYPERTENSION) in Clinical Pharmacy and Therapeutics. The JNC 4 report (HYPERTENSION) in Clinical Pharmacy and Therapeutics, 5, 583-589.
17. Robert Weibert (1996). The JNC 5 report (HYPERTENSION) in Textbook of Therapeutics, Drug and disease management. The JNC 5 report (HYPERTENSION) in Textbook of Therapeutics, Drug and disease management, 6, 701-705.
18. Robert Weibert (2000). The JNC 6 report (HYPERTENSION) in Textbook of Therapeutics, Drug and disease management. Eric T. Herfindal et al Ed, 7, 42-47.
19. Stephen M Setter,J John R White,R Lard,Keith Campbell (2006). Diabetics in Text book of therapeutics, Drug and Disease management. Diabetics in Text book of therapeutics, Drug and Disease management
20. Richard Helms Unknown Title.
21. M Stern (1998). The effect of glycermic control on the incidence of macrovascular complication. Type 2 diabetics. Arch. Fom . Med, 7, 155-162.
22. W Sweileh,O; Aker,S Hamooz (2005). Rate of compliance among patients with Diabetes Mellitus and Hypertension. An-Najah University Journal for Research -Natural Sciences‖, 19, 1-12.
23. R Turner,R Holman,I; Stratton,C; Cull,V; Frighi,S; Manley,S Matthews,A; Neil,H; Mcelroy,E; Koliner,C; Fox,D; Hadden,D Wright (1998). Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ, 317(7160), 703-713.
24. (1998). Intensive blood glucose with Sulfony lureas or Insulin compared with conventional treatment and risks of complications in patient with type 2 diabetes (UKPDS 33). Lancet, 353, 837-853.
25. U Pds) Group (1998). Effect of intensive glucose with metformin on complications in overweight patient with type 2 diabetes (UKPDS 34). Lancet, 352, 854-865.
26. (1998). Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes.(UKPDS 38). Br Med J, 317, 703-713.
27. (1998). Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ, 317(7160), 713-720.
